Translate Bio to Participate in Citi’s 13th Annual Biotech Conference
30 août 2018 07h30 HE
|
Translate Bio, Inc.
LEXINGTON, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements
09 août 2018 16h17 HE
|
Translate Bio, Inc.
-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis ---- Established strategic mRNA vaccines partnership with Sanofi Pasteur ---- Completed initial public offering...